PRUEBA RÁPIDA DE TUBERCULOSIS IGG/IGM AB TRI-LÍNEAL
Mexico·Clase II·III. Agentes de
diagnóstico·QUIMIBIOL, S.A. DE C.V.·Registered June 10, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- MEXLAB BIO- TUBERCULOSIS IGG/IGM AB PRUEBA RÁPIDA CON TRES LINEAS EN CASETE
- Trade Name (English)
- MEXLAB BIO- TUBERCULOSIS IGG/IGM AB PRUEBA RÁPIDA CON TRES LINEAS EN CASETE
- Analysis ID
- 1680R2024 SSA
- Registration Date
- June 10, 2024
- Name (Spanish)
- QUIMIBIOL, S.A. DE C.V.
- Name (English)
- QUIMIBIOL, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA RÁPIDA DE TUBERCULOSIS IGG/IGM AB TRI-LÍNEAL (PRUEBA RÁPIDA DE TUBERCULOSIS IGG/IGM AB TRI-LÍNEAL) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1680R2024 SSA and manufactured by QUIMIBIOL, S.A. DE C.V.. The device was registered on June 10, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.